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Abstract A major public health goal is to determine
linkages between specific pollution sources and adverse
health outcomes. This paper provides an integrative
evaluation of the database examining effects of vehicular
emissions, such as black carbon (BC), carbonaceous gasses,
and ultrafine PM, on cardiovascular (CV) morbidity and
mortality. Less than a decade ago, few epidemiological
studies had examined effects of traffic emissions specifi-
cally on these health endpoints. In 2002, the first of many
studies emerged finding significantly higher risks of CV
morbidity and mortality for people living in close proximity
to major roadways, vs. those living further away. Abundant
epidemiological studies now link exposure to vehicular
emissions, characterized in many different ways, with CV
health endpoints such as cardiopulmonary and ischemic
heart disease and circulatory-disease-associated mortality;
incidence of coronary artery disease; acute myocardial
infarction; survival after heart failure; emergency CV
hospital admissions; and markers of atherosclerosis. We
identify numerous in vitro, in vivo, and human panel
studies elucidating mechanisms which could explain many
of these cardiovascular morbidity and mortality associa-
tions. These include: oxidative stress, inflammation, lip-
operoxidation and atherosclerosis, change in heart rate
variability (HRV), arrhythmias, ST-segment depression, and
changes in vascular function (such as brachial arterial
caliber and blood pressure). Panel studies with accurate
exposure information, examining effects of ambient com-
ponents of vehicular emissions on susceptible human
subjects, appear to confirm these mechanisms. Together,
this body of evidence supports biological mechanisms
which can explain the various CVepidemiological findings.
Based upon these studies, the research base suggests that
vehicular emissions are a major environmental cause of
cardiovascular mortality and morbidity in the United States.
As a means to reduce the public health consequences of
such emissions, it may be desirable to promulgate a black
carbon (BC) PM2.5 standard under the National Ambient
Air Quality Standards, which would apply to both on and
off-road diesels. Two specific critical research needs are
identified. One is to continue research on health effects of
vehicular emissions, gaseous as well as particulate. The
second is to utilize identical or nearly identical research
designs in studies using accurate exposure metrics to
determine whether other major PM pollutant sources and
types may also underlie the specific health effects found in
this evaluation for vehicular emissions.
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Introduction
Method of assessing effects of vehicular emissions
on cardiovascular endpoints
A considerable literature base is now available relating
cardiovascular (CV) health effects from exposure to
ambient particulate matter (PM) deriving from various
sources. Specific components of PM from such sources—
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likely have differential health impacts.
Vehicular emissions consist of particulate and gaseous
emissions, with biologically active carbonaceous products
present in both phases. Black carbon, mainly from diesels,
is found in ultrafine and fine size fractions, mainly less than
1μm in size and predominantly below 0.18μm (Mauderly
and Chow 2008). Such vehicular particulates are often
coated with condensed organic and inorganic compounds
(Mauderly 2001; Health Effects Institute 1995). Approxi-
mately 75% of diesel PM2.5 emissions consist of such
carbon (Health Effects Institute 2003). While particulate
vehicular emissions per se, notably in the ultrafine fraction,
have been specifically associated with endpoints such as
oxidative stress and mitochondrial damage (Li et al. 2003),
lipid peroxidation (Pereira et al. 2007), upregulation of
genes relevant to vascular inflammation (Gong et al. 2007),
and early atherosclerosis and oxidative stress (Araujo et al.
2008), non-particulate emissions have also been specifically
linked to a variety of health endpoints (Mauderly and
Chow 2008).
Our evaluation begins with the considerable amount of
epidemiological evidence which has become available
mainly since 2002 linking vehicular emissions with a range
of CV outcomes. We then examine in vitro, in vivo, and
human panel studies to understand if biological mecha-
nisms have been identified in such studies which would
explain the epidemiological findings for each CVoutcome.
Many of these studies use diesel emissions or diesel
emission particulates, or evaluate effects from ambient air
collected near highways in major cities with associations
found with black carbon, mainly a diesel emission. Thus,
our assessment assesses the coherence of results across
different methodologies for CV endpoints, related to
vehicular emissions.
Interpretation of studies related to accurate exposure
assessment
Before reviewing epidemiological evidence linking vehic-
ular emissions with CV endpoints, it is important to
understand how differences among studies in accuracy of
subject exposure to spatially variable emissions such as
vehicular emissions can affect the strength and biological
significance of associations.
Many epidemiological and panel studies use data from
central monitors to characterize exposure to pollutants
which may have considerable local variability and thus
do not accurately characterize subjects’ exposure to these
emissions (Ito et al. 2004). Using central monitors or
other less precise exposure estimation methods will result
in underestimates of risks (Zeger et al. 2000), including
those from vehicular emissions (Adar and Kaufman 2007).
In multi-pollutant models, differential exposure error may
cause risks to be transferred from variables having more
exposure error to those having less (Goldberg and Burnett
2003; Hennekens and Buring 1987). Thus, it is essential to
understand to what extent currently available studies
include accurate assessment information for pollutants
that might be particularly harmful, and to assess how these
exposures relate to the magnitude and significance of risk
estimates. This type of evaluation is necessary to deter-
mine whether emissions from specific sources rather than
others may be more critical to regulate so as to preserve
public health. Even with subject exposure misclassifica-
tion, positive significant associations are not ruled out;
however, in such a case, they are likely understated (Zeger
et al. 2000).
This paper attempts to address these issues for vehicular
emissions as they relate to CV health endpoints, with
emphasis on epidemiological investigations incorporating
reasonably accurate subject exposure information. We
define “reasonably accurate exposure” as that exposure
metric resulting from a methodology in which the measured
exposure concentration varies with and, therefore, reflects
reasonably closely the actual exposure for the population
that is being assessed for adverse health outcomes.
Methodologies which meet this criteria would include (1)
personal monitors, (2) monitors which follow subjects
closely as they go about their daily activities, (3) studies
which use a combination of wind trajectories and pollution
measurements to understand what sources were influencing
exposure in the time period(s) of interest, and (4) studies in
which the monitor was in close proximity to a roadway, and
the subjects of the study also lived in close proximity to the
same roadway not far distant from the monitor (Grahame
2009). On the other hand, an epidemiological study using a
central monitored concentration and using this concentra-
tion as an exposure metric for subjects living over a wide
area represents inaccurate exposure for traffic-related
emissions, because such emissions have substantial vari-
ance across a city (Ito et al. 2004) and even within 100 m of
a major highway vs. further away (Zhu et al. 2002a, b). A
fuller discussion of these issues is found in Grahame
(2009), which considers formally whether health effect
associations vary consistently among studies which use
reasonably accurate subject exposure information for
spatially variable emissions such as BC, vs. studies using
centrally monitored concentrations as a proxy for exposure
to such local emissions.
The vehicle/traffic emissions category was selected
since there is a large and growing evidence base suggesting
that traffic-related pollution likely plays an important role
in adverse health outcomes associated with ambient
pollution such as urban PM, including black carbon (BC;
White et al. 2005; Samet 2007; Adar and Kaufmann 2007;
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primarily from diesel engines.
We first consider epidemiological studies which utilize
information relating proximity of residence to major roads,
to determine the extent to which such proximity may be
associated with health outcomes such as all-cause or
cardiovascular mortality and morbidity. Some of these
studies examined associations of specific vehicular emis-
sions, e.g., BC as a marker of diesel emissions, with such
outcomes. Similar studies use modeled exposure to vehic-
ular emissions (BC, or mainly outside the U.S., NO2) at the
residence, or use traffic density as a proxy for exposure to
vehicular emissions (at county level or within 100 m of the
residence).
We then consider studies which examine specific CV
biological endpoints, e.g., oxidative stress, inflammation,
change in EKG pattern (ST-segment depression), changes
in heart rate variability (HRV), vasoconstriction and
changes in blood pressure, arrhythmias, and lipoperoxida-
tion/atherosclerosis. Such studies can vary considerably in
accuracy of subject exposure; again, we emphasize findings
from studies with more accurate exposure information.
Toxicological evidence regarding specific biological mech-
anisms is also examined to understand if there might be
common threads which extend from toxicological through
panel studies to epidemiological evaluations.
Associations between vehicular emissions and lung
cancer, and mutagenicity of vehicular emissions, have been
reviewed elsewhere (Grahame and Schlesinger 2007) and
will not be reviewed here. Similarly, the ample literature
relating vehicular emissions and highway proximity to
respiratory morbidity endpoints, such as asthma, will not be
discussed.
Epidemiological evidence for association of vehicular
emissions with adverse cardiovascular health outcomes
Investigating health effects specific to vehicular emissions
in epidemiological studies has historically been problemat-
ic. Early studies did not monitor for pollutants most closely
related to vehicular emissions (e.g., BC) and, thus, could
not find associations with such emissions. Later reanalyses
of the early studies were sometimes able to parse out such
associations, despite the lack of vehicular pollution data
(e.g., the Jerrett et al. 2005 reanalysis of the American
Cancer Society cohort [Pope et al. 1995, 2002]). When
studies began to monitor specifically for vehicular emis-
sions such as BC, initial exposure assessment used central
monitor data and associations were often not robust. NO2 is
also seen as a marker of vehicular emissions, particularly in
European studies. Although NO2 is emitted from sources
other than vehicles, such as power plants and industry,
vehicular NO2 emissions usually dominate in busy urban
centers lacking major industry. In some cases, where
monitors were located in close proximity to major high-
ways, even SO2 and/or SO4 from different sources,
including diesels before the 2007 changeover to ultra-low
sulfur diesel fuel, may be intermixed (Grahame and Hidy
2007a, b).
Studies using central monitoring for several different
sources, including vehicles, did not always find daily
mortality or morbidity associated with vehicular emissions.
For example, Thurston et al. (2005)f a i l e dt of i n d
cardiovascular or non-accidental mortality associated with
a traffic emissions factor in either Phoenix or Washington,
DC, using different source apportionment models. Howev-
er, the daily mortality study of Laden et al. (2000) found
such associations, as did the Schwartz (2003) reanalysis of
Laden et al. (2000), necessitated by problems in the original
study with a statistical software package (which affected
many other studies as well). Another multi-city study
(Janssen et al. 2002) examined prevalence of air condition-
ing as an effect modifier, and found associations for daily
morbidity (hospital admissions for CV disease) with diesel
emissions, highway emissions, and vehicle miles traveled
per square mile (traffic density). Two recent studies based
in Atlanta (Sarnat et al. 2008; Tolbert et al. 2007) found
significant associations between vehicular emissions and
emergency department admissions for CV disease. Howev-
er, Metzger et al. (2007), in a study also in the Atlanta area,
failed to find associations between PM10,P M 2.5,o r
vehicular emissions with daily morbidity (i.e., arrhythmias).
Four of these six multi-pollutant studies found CV health
associations with vehicular emissions, but none of the
studies utilized exposure measurements known to reflect
subject exposure reasonably accurately, because all used
pollution measurements from central monitors as a proxy
for personal exposure. While these studies, taken as a
whole, suggest the importance of vehicular emissions for
the health endpoints examined, strength of effects may be
underestimated (Ito et al. 2004), and results are not always
consistent. Thus, the most credible studies linking spatially
variable vehicular emissions to various health effect
endpoints would be those which demonstrate that the
ambient pollutant concentrations utilized relate reasonably
well to actual exposure of populations examined for health
effects.
Concentrations of vehicular emissions have been shown
to drop by as much as an order of magnitude within 100 m
of a major freeway. People living nearby major roadways
will be exposed to greater amounts of vehicular emissions
such as BC, ultrafine PM, and gaseous emissions, than will
those living at a greater distance (Zhu et al. 2002a, b). As a
result, the studies first to show large adverse cardiovascular
effects clearly and consistently linked to vehicular emis-
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designed to isolate the health risks of living near a major
road from the traditional risk factors typically examined in
cohort studies.
Conducted first in Western Europe and Canada, and later
in the US, highway proximity studies found significantly
elevated risks for cardiovascular death or morbidity out-
comes and for all-cause mortality, for people living in close
proximity (usually 100 m to major roadways or 50 m to a
major urban road), compared to those living farther away.
Several utilized data from existing cohort studies, adding
only the highway proximity variables. In different ways and
to different degrees, these studies accounted for socioeco-
nomic and other variables which could confound pollution–
health associations. These studies include the following
(statistically significant associations are indicated):
& Finkelstein et al. (2004, 2005; all-cause mortality
[relative risk, RR=1.18] and circulatory disease mor-
tality [RR = 1.40], respectively);
& Hoek et al. (2002; cardiopulmonary mortality [RR=
1.95]);
& Gehring et al. (2006; cardiopulmonary mortality, RR=
1.70);
& Tonne et al. (2007; acute myocardial infarction [MI],
RR=1.04 to 1.06);
& Hoffmann et al. (2007; increased coronary artery
calcification: RRs=1.63 and 1.34 for distances of less
than 50 m and 51 to 100 m from highways, vs. more
than 200 m distant); and
& Hoffman et al. (2006; incidence of coronary heart
disease, RR of 1.85).
These RRs can be compared to RRs for all-cause and
cardiopulmonary mortality of 1.04 and 1.06 (per 10μg/m
3
increase in PM2.5) found in the American Cancer Society
(ACS) study (Pope et al. 2002). Finkelstein et al. (2004)
found a significant mortality rate advancement period of
2.5 years associated with residence near a major roadway.
Another method of associating mortality risks with
proximity to traffic and highways utilizes different meas-
ures of traffic density (e.g., annual vehicle miles per square
kilometer in a county, or daily vehicle kilometer within
100 m of a residence) as a proxy for exposure to vehicular
emissions. Relevant studies finding significant health
associations with traffic density measures include:
& Kan et al. 2008 (incidence of coronary heart disease
[CHD]; significant increase in CHD incidence hazard
ratio [HR] of 1.32 for those in highest quartile of traffic
density vs. lowest quartile, HR of 1.38 for those in
second highest quartile vs. lowest quartile);
& Janssen et al. 2002 (hospital admissions for CVD; one
interquartile range [IQR] increase in vehicle miles
traveled per square mile significantly associated with a
21.2% increase in CVD hospital admissions);
& Lipfert et al. 2006a, b (all-cause mortality; between
these two studies, 30 of 33 tests of traffic density
measures were significant, in single and multi-pollutant
models, with two different ways of stating risks, with
RRs centering around 1.16 in Lipfert et al. 2006a
1); and
& Medina-Ramon et al. 2008 (survival after heart failure;
an IQR increase in daily traffic within 100 m of home
significantly associated with a mortality HR of 1.12
after adjustment for SES, and with a HR of 1.30 for
those living within 50 m of a bus route).
The Medina-Ramon et al. (2008) study found that a
measure of traffic density (vehicle km within 100 m of
residence) was a stronger predictor of survival time after
heart failure than were other measures, such as similar
distance to a major roadway. This finding makes intuitive
sense—ideally, exposure should be a product of both
proximity and of the amount of pollution produced within
that proximity. Just as proximity of a residence to a major
highway is a better proxy for exposure to traffic emissions
than is centrally monitored PM concentrations, traffic
density within 100 m of a residence is likely a better proxy
than distance of 100 m from a major road. Distance to a bus
route was also an important predictor of survival in
Medina-Ramon et al. (2008), suggesting the importance of
diesel emissions.
Results of Kan et al. (2008) parallel findings of
Hoffmann et al. (2006), in that both studies controlled for
hypertension, a mechanism by which noise might cause
stress and, thus, by which traffic might cause coronary heart
disease via noise pollution rather than chemical pollution.
As a result, findings associating mortality and morbidity
risks to proximity to busy highways and traffic likely can
be attributed primarily to chemical pollution rather than to
noise.
Using geographic modeling systems to relate individual
residences to either traffic emissions concentrations, dis-
tance to major roads, or traffic intensity, other studies also
found elevated levels of vehicular pollutants to be associ-
ated with adverse cardiac-related health outcomes. Exam-
ples include:
& Rosenlund et al. (2006;N O 2 modeled to home
significantly associated with out-of-hospital deaths,
OR of 2.17 for a 5% to 95% increase in NO2 [in
Stockholm, Sweden]);
1 The traffic density was insignificant only when EC was also
included in a multi-pollutant model; in these cases, both variables
came close to significance, but traffic density appeared to be the
stronger of the two.
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cause mortality per IQR increase in BC modeled to
home);
& Beelen et al. (2008; significant RR of 1.05 for all-cause
mortality for a 5% to 95% increase in black smoke);
and,
& Nafstad et al. (2004; significant RR of 1.11 for ischemic
heart disease mortality associated with a 10μg/m
3
increase in NO2 at home [in Oslo, Norway]).
Finally, Peters et al. (2004) found that a first MI was
significantly associated with being in traffic 1 h prior to the
event (odds ratio 2.92).
What all of these studies have in common is a
demonstration that people exposed to the higher levels of
traffic emissions found close to major urban roads or
freeways, or modeled to their homes, have higher long-term
risks for ischemic heart disease, acute MI morbidity and
mortality, and all-cause mortality, or increased risks of a
first-time MI with short-term exposure to traffic pollution.
These studies, with reasonably accurate subject exposure
information for traffic emissions, have results which often
(but not always) contrast with studies using central
monitors.
Several studies noted above also associated BC or its
near equivalent, black smoke, with increased morbidity and
mortality risks. Hoek et al. (2002) found risks of cardio-
pulmonary mortality significantly associated with black
smoke (local plus background, RR=1.71; background
black smoke, RR=1.34), suggesting the greater effects of
fresh, local roadway black smoke. Maynard et al. (2007)
found that an increase of one IQR (interquartile range) in
previous days BC exposure was associated with a signif-
icant increase of 2.3% in all-cause mortality in single-
pollutant models, and of 2.2% in two pollutant models.
Beelen et al. (2008) found significant increases in all-cause
and respiratory mortality associated with black smoke and/
or NO2 but not with PM2.5 or SO2. Nafstad et al. (2004)
found a 10μg/m
3 increase in nitrogen oxides at the home to
be associated with significant increases in all-cause and
ischemic heart disease mortality of 1.08 and 1.11, respec-
tively. Relative risks of cardiopulmonary mortality of 1.57
and of all-cause mortality of 1.17 were related to near-
highway NO2 exposure in Gehring et al. (2006). Rosenlund
et al. (2006) found an odds ratio for out-of-hospital death of
2.17 related to NO2 exposure.
Mechanistic bases for adverse cardiovascular health
outcomes from vehicular emissions-derived PM
In order to provide mechanistic plausibility for the
epidemiological findings noted above, it would be helpful
to have information about specific conditions or biological
responses which could lead to these reported health
outcomes. Such information can be derived from in vitro
and in vivo toxicology studies, as well as from human panel
studies using vehicular emissions or ambient air.
Personal monitors would provide better exposure assess-
ment than would a proxy for personal exposure, such as
distance of residence from a major road, or modeled
exposure at one’s home. Although each of these proxies
provides far better exposure differentiation than would a
central monitor reading applied to all residents in a locality,
there will still be differences in daily activity patterns and,
thus, exposures, among similarly situated people. For
obvious reasons, cohort studies of mortality and of many
morbidity outcomes such as hospital admissions for CV
disease could not utilize personal monitors. However, for
certain short-term morbidity outcomes with fairly high
frequencies, such as change in HRV, ST-segment depres-
sion, and arrhythmias, the use of personal pollution
monitors or their equivalent may be possible.
Oxidative stress
Oxidative stress is a mechanism postulated to be involved
in various PM-induced cardiovascular health effects, in-
cluding chronic heart failure (McMurray et al. 1993), acute
heart failure (especially when patients had atrial or
ventricular arrhythmia [Charniot et al. 2008]), and atrial
fibrillation (AF; Neuman et al. 2007). Kim et al. (2003)
found in AF patients that gene expression profiles for
reactive oxygen species were upregulated, while those for
anti-oxidants were downregulated. Iravanian and Dudley
(2006) suggest a unifying hypothesis that there are multiple
triggers for oxidative stress and that oxidative stress,
whatever the origin, causes AF. Furthermore, AF itself
can result in further oxidative stress, creating a positive
feedback loop.
Chahine et al. (2007) found that individuals lacking
genes protective against oxidative stress (GSTM1 and the
short repeat variant of HMOX-1), but not those with such
genes, are vulnerable to HRV changes due to pollution
exposure. Instillation of urban air particles and inhalation of
concentrated ambient air particles caused oxidative stress in
the heart in vivo, as well as reduction in HRV (Rhoden et
al. 2005); increases in heart oxidant levels were demon-
strated by increases in chemiluminescence or TBARS.
Oxidant effects were abolished by the anti-oxidant, NAC.
When oxidative stress was abolished, HRV returned to
normal (Rhoden et al. 2005). Thus, findings of both
Chahine et al. (2007) and Rhoden et al. (2005) suggest
that reductions in HRV appear to be due to increased
oxidative stress. If this is true, then lack of HRV changes
may indicate lack of oxidative stress in some to many cases.
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nistically linked to cardiac pathophysiology, we next review
studies which find that exposure to vehicular emissions
generally, and to diesel emissions specifically, are linked to
oxidative stress.
Pereira et al. (2007) found that in vivo exposure to
ambient emissions taken adjacent to a busy road in Porto
Alegre, Brazil caused oxidative stress and lipid peroxida-
tion in rat lungs. Similarly, Huang et al. (2003) found that
PM1.0 was more likely to cause lipid peroxidation in human
bronchial epithelial cells than either PM1.0–2.5 or PM2.5–10,
and that the components of PM1.0 associated with increased
lipid peroxidation were organic carbon (OC) and elemental
carbon (EC), but not various ions.
A number of studies suggest that diesel emissions, most
specifically ultrafine PAH, appear to be associated with
increased levels of cellular oxidative stress. As reviewed in
Grahame and Schlesinger (2007), a series of studies
demonstrated the ability of both diesel emissions and of
ambient air in Los Angeles to cause oxidative stress in vitro
in bronchial epithelial cells. These effects were highly
correlated with organic carbon and PAH content. Briefly, Li
et al. (2002a) found that organic diesel emission particles
(DEP) caused oxidative stress in vitro (marked by increases
in heme oxigenase-1, HO-1), and Li et al. (2002b) found
that concentrated emissions from Los Angeles air, collected
from near a major freeway, also caused increases in
oxidative stress, e.g., in HO-1. Ultrafine (UF) fractions of
Los Angeles air stimulated higher production of HO-1 than
did larger PM fractions (Li et al. 2003). Production of HO-1
was correlated with the organic and PAH content of the
ultrafine PM. Electron microscopy showed these UF
particles penetrated into subcellular structures more easily
than did larger particles, and damaged mitochondria. Taken
together,theseinvitrostudiesofLosAngelesairsuggestthat
the ultrafine fraction of diesel emissions in Los Angeles air,
likely including ultrafine BC coated with a mix of organic
compounds, appear to be causally related to the increases in
oxidative stress also found to be caused by organic DEP.
Findings of oxidative stress were confirmed in vivo, in a
study where HO-1 levels in mice exposed to the exhaust of
a normally running newer diesel increased significantly vs.
filtered air control (McDonald et al. 2004). Furthermore,
when a new catalytic trap was retrofitted on the diesel, most
of the carbonaceous emissions were reduced by large
percentages, BC was entirely oxidized, and the HO-1 levels
were no longer elevated.
The panel study of Delfino et al. (2008) used indoor and
outdoor monitors at the residences of 29 non-smoking
elderly subjects with coronary artery disease living in Los
Angeles. Decreased levels of an anti-oxidant enzyme were
significantly associated with increased concentrations of
BC, primary OC of outdoor origin, NO2, and ultrafine PM.
Mills et al. (2005) exposed healthy human volunteers to
diluted diesel exhaust (300μg/m
3) or to filtered air for 1 h
in a double-blind, randomized, crossover study. The authors
found that inhalation of diesel exhaust impaired the
regulation of vascular tone and endogenous fibrinolysis.
Net release of “clotbusting” t-PA antigen was significantly
reduced 6 h after exposure. The authors postulated that
effects might be caused by reduced availability of nitric
oxide (NO) in the vasculature due to oxidative stress
induced by the ultrafine particle fraction of diesel exhaust,
providing a mechanistic link for associations between PM
and acute MIs. Consistent with this supposition, previous
work has found that the ultrafine fraction of diesel
emissions (likely with adsorbed carbonaceous species)
causes greater levels of oxidative stress than larger fractions
(Li et al. 2002a, b, 2003; Araujo et al. 2008). The results of
Mills et al. (2005) suggest one possible explanation for the
significant finding of an initial myocardial infarction in 1 h
after being in traffic (as a driver or on public transit) noted
by Peters et al. (2004), and for increases in cardiovascular
mortality linked to traffic emissions on high pollution days
(Schwartz 2003).
Because of its potential to be involved in various specific
aspects of CV pathophysiology, further discussion of the
role of oxidative stress in pollutant-related health outcomes
is provided in discussions of individual CV endpoints
below.
Alteration in heart rate variability
Many recent studies assess HRV, which refers to alterations
in the beat to beat heart rate and is regulated by the
autonomic nervous system. While normal sinus rhythm is
characterized by regular R–R intervals in the EKG, the
heart does normally show some variability from beat to
beat, which can be measured by examination of these
intervals. HRV changes appear to be predictive of MI for
those who have had a previous MI (Tapanainen et al. 2002),
or who have chronic congestive heart failure (Bilchick et al.
2002). Schwartz et al. (2005a) found that in those lacking
the allele for glutathione-S-transferase M1 (GSTM1), a
component of the cellular defense against oxidative stress,
PM2.5 effects on HRV (a decrease in high-frequency
component, HF) is mediated by reactive oxidant species.
Use of statins, which have anti-oxidant effects, eliminated
the effects of PM2.5 on HRV. Thus, while changes in HRV
may be a cause of cardiac mortality, in particular for those
who have had a previous MI, it also appears to be another
possible sequela of oxidative stress in the heart (Rhoden et
al. 2005; Schwartz et al. 2005a), which has broader health
implications than change in HRV alone.
Several recent studies with accurate exposure informa-
tion suggest that either vehicular emissions specifically, or
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HRV. A literature search was performed to find studies of
HRV which used ambient air and human subjects in the US,
and which monitored for at least two of the three pollutants
(PM2.5, BC, sulfate).
Adar et al. (2007) used a mobile monitor, which
followed 44 non-smoking elderly residents of a seniors’
home who were going about daily activities, and found
significant associations between increased BC exposure for
the entire period and changes in six measures of HRV (see
Table 1), for two different time periods, a total of 12
significant associations in 12 tests. When the subject
boarded a bus and BC concentrations rose by about an
order of magnitude, changes in most HRV measures were
similar.
Schwartz et al. (2005b) examined HRV in 27 seniors
living in close proximity to a busy urban road in Boston.
The monitor, located about 0.5 km distant from the living
quarters and also adjacent to the same road, recorded BC
and PM concentrations which would mirror concentrations
at the residences reasonably well (because of similar close
proximity to the major urban road). The investigators found
in six of eight tests (four HRV measures, two time frames),
that increased BC was significantly associated with changes
in different measures of HRV (a seventh test was borderline
significant). PM2.5 was significantly associated in two of
eight tests. When an algorithm was used to remove BC
from PM2.5 on an hourly basis and thus obtain a measure of
what the authors viewed as regional PM2.5 without fresh
BC and correlated emissions, no associations were found
between PM2.5 and HRV measures (Fig. 1). These findings
appear to show that previous studies which did not monitor
for BC and found associations with PM2.5, may have been
detecting unmeasured BC (i.e., vehicular) effects, and that
PM2.5 was associated with various changes in HRV only
when PM2.5 was highly correlated with BC, another finding
of Schwartz et al. (2005b).
Creason et al. (2001), in a study of 56 non-smoking
seniors with a mean age of 82, used wind trajectories to
determine which air masses (containing different types of
pollution) were associated with changes in HRV. The
authors initially found a “U-shaped” association between
increasing PM2.5 levels and decreasing HRV—as PM
concentrations increased from the lowest levels, HRV
reductions occurred with increasing PM2.5, but toward the
highest PM2.5 concentrations, HRV reductions reversed,
and the HRV measure returned to where it was at the lowest
PM2.5 levels (null effect). Inclusion of a 2-day air mass with
high PM2.5 (highest and third highest of 24 days) had
caused the reversion. On these 2 days, the investigators
found, wind trajectories showed that the air masses had
come from rural north-central Pennsylvania. When these
2 days were removed from the analysis, there was a
monotonic decrease in HRV with increasing PM, similar to
the monotonic decrease in PM found in Schwartz et al.
(2005b) when the PM was highly correlated with urban BC.
The authors noted that HRV reductions were found when
the emissions reflected urban or industrial activity, but that
there was no toxicity in the 2 days with high PM from rural
areas.
Similar effects were noted by Park et al. (2007), a study
of 487 male veterans. The authors found that trajectories
reflecting urban emissions (either a stagnant local air mass
in Boston or an air mass transported from the Washington,
DC through New York City corridor) were associated with
changes in several HRV measures. Two other trajectories
reflecting mostly rural air masses were not so associated,
even though monitored levels of sulfate, BC, and PM2.5
were very similar among the air masses. Finally, Ebelt et al.
(2005) used personal monitors in a panel study of 16 non-
smoking COPD patients, and found that local urban
particles, but not sulfates, were associated with HRV
changes.
All these above-studies are characterized by reasonably
accurate exposure information, whether for BC (Adar et al.
2007; Schwartz et al. 2005b), for PM in urban/industrial air
masses vs. rural air masses (Creason et al. 2001; Park et al.
2007) or for urban emissions vs. sulfate (Ebelt et al. 2005).
The two studies which monitored for BC (Adar et al. 2007;
Schwartz et al. 2005b) showed consistently significant
associations between changes in HRV measures and BC
concentrations, with virtually no insignificant associations.
Further, HRV changes were essentially monotonic with
increasing BC levels in these studies.
Since the main contributor to “urban excess” PM2.5 is
vehicular emissions marked by carbonaceous species (Rao
et al. 2002), the urban vs. rural air mass results are
consistent with results of exposure to higher BC and
vehicular emissions in an urban area. Furthermore,
Anselme et al. (2007) exposed Wistar rats (ten healthy,
ten with chronic ischemic heart failure, CHF) to diluted
diesel emissions. Immediate decreases in a HRV measure
(RMSSD) were observed in both healthy and CHF rats
following exposure, a finding which parallels the reductions
in HRV found in Schwartz et al. (2005b) and Adar et al.
(2007) in association with increased BC exposure.
Other extant studies lacking accurate exposure informa-
tion for locally variable emissions because they used central
monitor readings for subjects living over a wide area,
generally showed weak (Wheeler et al. 2006; Park et al.
2005) or non-existent (Luttmann-Gibson et al. 2006)
associations for locally variable BC (Table 1), while some
studies with central monitor readings still found associa-
tions with vehicular emissions (de Hartog et al. 2009). The
exposure assessment for Luttmann-Gibson et al. in partic-
ular, uses a monitor several hundred feet in the air, adding
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Study Subject
exposure method
Characterization of HRV changes BC levels
A. In vivo animal study
1. Anselme et al. (2007) Healthy and CHF
rats exposed to
diesel emissions
Immediate decrease in RMSSD
in both CHF and healthy rats
immediately after exposure,
returning to baseline after 2.5 h
BC not measured
B. Human studies
with accurate
exposure
1. Schwartz et al.
(2005b)
Subjects lived adjacent
to same urban road to
which monitor was
adjacent, less than
1 km distant
Monotonic decrease in SDNN
with increase in BC exposure;
significant BC associations in
seven of eight tests (SDNN,
RMSSD, PNN50, LF/HF, 1
and 24-h averages); no
significant associations in eight
tests for PM2.5 without BC
(“non-traffic secondary particles”)
BC mean=1.2μg/m
3
2. Adar et al. (2007) Monitor followed
subjects during
activities, in
residence at night
For change of one IQR, BC
significantly associated with
changes in all six measures of
HRV, for both 5-min and 24-h
means; sharply increased
exposure to BC when subjects
on buses associated with changes
of similar magnitude in all six
HRV measures (decreases in SDNN,
PNN50+1, RMSSD, LF, and HF;
increase in LF/HF), similar to
Schwartz et al. (2005b)
BC mean not given;
BC IQR for all periods
was 330 ng/m
3; for bus
periods, IQR was
2911 ng/m
3
3. Riediker et al.
(2004b)
Presence of young
patrol officers in vehicle
for 9 h before tests
Significant increases in SDNN,
PNN50 associated with “speed
change” source factor, (braking
and diesel emissions), but not
“crustal,”“ steel wear” or
gasoline factors
BC not measured
4. Ebelt et al. (2005) Personal monitors
in panel study in
Vancouver
Estimated non-sulfate urban PM2.5
associated with decreased
RMMSD, sulfate not associated
BC not measured
C. Human studies using
central monitors not
far from street level
(horizontal exposure
misclassification)
1. Wheeler et al. (2006) Central monitor for
greater Atlanta area
subjects
EC associated with SDNN changes
in only one of four tests, NO2 in
only 4 of 13 tests; authors discuss
exposure error due to spatial
variability of NO2, note “this greater
exposure error is consistent with
the fact that traffic, which varies
spatially over short distances, is a
significant source of outdoor NO2.”
EC mean=1.6μg/m
3
2. Park et al. (2005) Central monitor for
subjects living within
40 km of monitor
BC associated with one of four
measures of HRV changes; exposure
discussed in context of PM2.5
(little exposure error) but not
discussed for BC
BC mean=0.92μg/m
3
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al. 2004) to the horizontal exposure misclassification (Ito et
al. 2004) found in Wheeler et al. (2006) and Park et al.
(2005). We are unaware of any study with reasonably
accurate exposure information for BC or for urban
emissions which fails to find associations between such
emissions and HRV alteration when the latter was exam-
ined. A detailed review of US HRV studies utilizing
ambient air and human subjects concludes that results of
these studies appear to vary consistently with accuracy of
exposure to vehicular emissions (Grahame 2009), with
consistently strong BC associations with changes in various
measures of HRV, almost always significant, only when BC
exposure measures are reasonably accurate.
In a study of 643 healthy men and women aged 55 to 75
and with no prior history of heart disease or stroke,
Sajadieh et al. (2004) suggested the possibility of inter-
actions between HRV changes (imbalance in sympathetic
system) and subclinical inflammatory processes in promot-
ing atherosclerosis. Thus, there are likely linkages between
various aspects of cardiopulmonary pathophysiology relat-
ed to pollutant exposure.
ST-segment changes
The ST interval in the EKG represents the period during
which the ventricles depolarize. A depression in the ST-
segment is associated with increased risk for future cardiac
events; those with undetected ST-segment depression have
significantly greater risk of death from cardiovascular
disease and stroke (Kurl et al. 2003). Pekkanen et al.
(2002) found elevated levels of PM2.5 mass in urban areas
to be associated with ST-segment depression, but could not
determine which specific components of PM2.5 resulted in
such a response. On the other hand, Gold et al. (2005), in a
study with the same reasonably accurate exposure protocol
as its companion study (Schwartz et al. 2005b), found BC
strongly associated with ST-segment depression. Total
PM2.5, which would include a mixture of both regional
and local pollution, was not associated with ST-segment
depression in this study.
2 Lanki et al. (2006) found that of
several local and regional pollutants, only a traffic factor
marked by absorbance coefficient (ABS, similar to black
carbon) was associated with ST-segment depression. Sub-
ject exposure in Lanki et al. (2006), however, was based on
central monitor readings.
2 Another vehicular emission, CO, was also so associated, but in a two
pollutant model with BC was no longer significant. In studies from the
1970s and 1980s, CO was found to be significantly associated with
various health endpoints, but CO levels were more than an order of
magnitude higher in the 1970s than they are today.
Fig. 1 SDNN monotonically decreases with increased PM2.5 when
PM2.5 is highly correlated with BC, but is not affected by rising levels
of PM2.5 when PM2.5 is higher and correlated with regional PM, but
not BC [from Schwartz et al. (2005b), reproduced with permission]
Table 1 (continued)
Study Subject
exposure method
Characterization of HRV changes BC levels
D. Studies using highly
elevated central
monitors (horizontal
and vertical exposure
misclassification)
1. Luttmann-Gibson
et al. (2006)
Central monitor elevated
400 feet above town
where subjects lived,
a mile from monitor
For IQR change in PM2.5 or sulfate,
significant reductions in SDNN,
RMSSD, HF, and LF (sulfate borderline
for LF), no associations for BC;
exposure error not discussed
BC mean=1.0μg/m
3
SDNN standard deviation of normal-to-normal intervals, RMSSD square root of mean squared difference between adjacent normal-to-normal
intervals, PNN50 percentage of adjacent normal-to-normal intervals differing by more than 50 ms, HF high-frequency power, LF low frequency
power, LF/HF ratio LF to HF, RR risk ratio, OR odds ratio, IQR interquartile range increase, SD standard deviation
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exposure characterization as did Gold et al. (2005), both of
these studies came to the same conclusion, namely, that
vehicular emissions marked by BC or ABS were associated
with ST-segment depression. This endpoint, as well as
HRV/oxidative stress in the heart and arrhythmias, is
among the likely causes for a first-time MI 1 h after being
in traffic (Peters et al. 2004).
In a double-blind, random crossover study (Mills et al.
2007), subjects with coronary heart disease were exposed
for 1 h to diluted diesel exhaust or filtered air (alternating
15 min of mild exercise with 15 min of rest). ST-segment
depression occurred in both sets of subjects, but the average
change in ST-segment depression was twice as great in
subjects exposed to diluted diesel exhaust. This result with
diesel emissions parallels results of the two epidemiological
studies of this endpoint reviewed above, which found
associations with BC or its equivalent, ABS.
Yan et al. (2008) examined left ventricular function in
healthy rats exposed to diesel exhaust particles (NIST
standard) and in those subjected to isoproterenol-induced
injury as a model for congestive heart failure. Diesel
exhaust particles impaired left ventricular functioning, such
as end diastolic diameter, in healthy mice, and this was
further impaired in the myocardial injured animals. This
suggests that acute exposure to these particles may result in
exacerbation of congestive heart failure, which supports
epidemiological findings of an association between PM
components, fine PM, OC, and EC, and hospital admissions
for congestive heart failure (e.g., Metzger et al. 2004).
Cardiac arrhythmia
Although some studies have associated measures of air
pollution with arrhythmias monitored by implantable
cardioverter-defibrillators (ICDs), none to date have utilized
either personal pollution monitors or ambient monitors
which follow residents of a seniors’ home, or the specific
exposure protocol of Schwartz et al. (2005b) and Gold et al.
(2005). Thus, the available database having good spatial
exposure information, and which would also allow evalu-
ation of those pollutants that may be important for
triggering arrhythmias, is limited.
Albert et al. (2007) examined risks of an ICD shock
during and after driving, finding increased risk in the hour
after driving (significant RR=2.24). The risks were specific
for ventricular tachycardia or ventricular fibrillation (VT/
VF), which occurred primarily in the half hour after driving
(RR=4.46, CI=2.92 to 6.82). These risks are similar to but
higher than the risks for a first MI found by Peters et al
(2004) in the first hour after being in traffic (odds ratio
2.92; 95% CI=2.22 to 3.83). Charniot et al. (2008) found
that oxidative stress in the heart was linked to acute heart
failure when a subject had a ventricular arrhythmia. Thus,
ventricular arrhythmias and oxidative stress, both of which
are linked to exposure to vehicular emissions, together
appear to contribute to acute heart failure. However, the
role of oxidative stress as a specific cause of such
arrhythmias is not yet fully understood. If oxidative stress
were to be the cause of VT/VF, then the studies linking BC
to HRV/oxidative stress (e.g., Schwartz et al. 2005b; Adar
et al. 2007) would point to BC as a primary cause of
arrhythmias as well. The actual cause of the oxidative stress
could be BC itself, emissions adsorbed onto the BC, and/or
emissions highly correlated with BC.
Riediker et al. (2004a, b) examined 11 different health
endpoints, including changes in supraventricular ectopic
(SVE) beats, an arrhythmia variable, in healthy young
patrol officers. Measurements for this endpoint took place
10 h after a 9-h duty shift on roads and highways. Using the
suite of emissions measured, the authors established three
different factors of emissions, reflecting PM on road surfaces,
gasoline emissions, and a “speed change” factor reflecting
accelerating diesels and brake wear. Increases in SVE beats
were associated only with the speed-change factor.
Ebelt et al. (2005) also found, in a study using personal
monitors, increases in SVE beats associated with ambient
urban PM and ambient non-sulfate PM, but not with sulfate,
in a panel study in the Vancouver area. Table 2 shows results
of studies of vehicular emissions and arrhythmias, stratified
as in Table 1 by accuracy of exposure.
Peters et al. (2000) examined the incidence of arrhyth-
mias among 100 patients in eastern Massachusetts in
relation to various air pollutants (PM10,P M 2.5, BC, NO2,
SO2, CO, O3) measured in South Boston. Associations
were found with PM2.5, BC, CO, and NO2 with a 2-day lag.
The strongest associations were found for BC and NO2,
which the authors took as evidence of effects of local
traffic. However, because of exposure misclassification, BC
and NO2 effects were likely underestimated, a possibility
suggested by others (Zeger et al. 2000; Ito et al. 2004) and
discussed by authors of several studies with exposure error
(Tables 1 and 2). As Peters et al. (2000) noted, “…we
would expect any exposure misclassification [for a centrally
monitored emission] to…bias the estimates toward the null.”
Dockery et al. (2005) followed 203 cardiac patients with
implanted ICDs living in metropolitan Boston for an
average of 3.1 years each between 1993 and 2002.
Pollution (PM2.5, BC, SO4, particle number, NO2, CO,
SO2,O 3) was monitored at several sites in the metropolitan
area. Average concentrations were derived for pollutants
with multiple measurements. No significant associations for
ventricular tachyarrhythmias were found for an interquartile
range increase in any pollutant, for a 2-day pollution mean.
However, when stratifying by a recent arrhythmia, signif-
icant associations were found for PM2.5, BC, NO2, CO and
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Study Subject exposure method Risks of arrhythmia
A. In vivo animal study
1. Anselme et al. (2007) CHF rats exposed to diesel
emissions; no effect in
healthy rats
200% to 500% increase in
ventricular premature beats,
persisting up to 5 h after exposure
B. Human studies with
accurate exposure
1. Albert et al. (2007) Presence in vehicle
before ICD events
RR of ICD shock in hour after
driving =2.24; RR of ventricular
tachycardia or ventricular fibrillation
in half hour after driving =4.46
2. Riediker et al. (2004b) Presence of young patrol
officers in vehicle for 9 h
before tests
∼ 40% increase in SVE beats per
change of one SD in “speed change”
source factor (braking and diesel
emissions), but not in “crustal,”
“steel wear” or “gasoline” factors
3. Ebelt et al. (2005) Personal monitors in panel
study in Vancouver area
Ambient and estimated PM2.5, non-sulfate
PM2.5 each associated with ∼ln 0.2 SVE
effect estimate; sulfate not associated
a
C. Human studies using central monitors not far from
street level (horizontal exposure misclassification)
1. Peters et al. (2000) Central monitor for eastern
Massachusetts area subjects
Risks highest for NO2 and BC, then
PM2.5; results seen by authors as related
predominantly to traffic emissions; OR
of ICD shock 2 days later =1.8 for 26 ppb
increase in NO2; due to single monitor,
authors’ expectation would have been to
bias estimates of gaseous emissions
toward null
2. Dockery et al. (2005) Central monitor for subjects living
within 40 km of monitor in Boston
Ventricular tachyarrhythmias
associated with BC, NO2, CO, and PM2.5,
for those with an arrhythmia in previous
3 days, authors see these as indicative of
vehicular emissions; for BC, OR=1.74 for
increase of 0.74μg/m
3 IQR exposure,
for NO2, OR=1.34 for 7.7 ppb IQR
increase; exposure misclassification discussed,
thought to weaken associations observed
3. Metzger et al. (2007) Central monitor data for patients
living in metro Atlanta area
No associations with ICD events with PM2.5,
NO2, CO, EC, OC, SO4; exposure
misclassification discussed, study “does
not contribute evidence regarding whether
personal exposure may be a determinant
of ventricular tachyarrhythmia”
4. Rich et al. (2006) Central monitor for subjects
living within 40 km
of monitor in Boston
No risk associations for paroxysmal atrial
fibrillation episodes with PM2.5,N O 2, BC,
CO, or SO2; associations only with ozone;
small number of episodes, thus reduced
statistical power discussed, but exposure
misclassification not discussed
D. Studies using highly elevated central monitors
(horizontal and vertical exposure misclassification)
1. Sarnat et al. (2006) Central monitor elevated
400 feet above town where
subjects lived, a mile from monitor
For 5-day moving average in pollution
concentration, OR for having an
SVE=1.42 for PM2.5; 1.70 for sulfate;
no associations for BC
RR risk ratio; OR odds ratio; IQR interquartile range increase; ICD implantable cardioverter-defibrillators; SVE supraventricular ectopy; SD
standard deviation
aAssociation taken from Fig. 2 in Ebelt et al. (2005). Association in Ebelt et al. also reported [in Sarnat et al. (2006)] as a 22% increase in rate of
SVE for subjects whose mean rate of SVE was 33 bph
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interquartile increase in the 2-day pollution mean; this
finding suggests that the most at-risk patients in general
may also be most at risk for a pollution-related ventricular
tachyarrhythmia. The authors took the associations with
PM2.5, CO, NO2, and BC as indicative of a link with motor
vehicle emissions, and the sulfate association as evidence of
a link with regional fossil fuel emissions. SO2 was highly
correlated with vehicular emissions and was seen as local in
origin. In light of the findings of Albert et al. (2007), the
lack of an association in this study with particle number,
which is considerably higher in the 100 m nearest a major
road (Zhu et al. 2002a, b), suggests that exposure
misclassification may also have occurred in this study,
perhaps understating effects of local vehicular emissions
and transferring health associations to other emissions
(Goldberg and Burnett 2003). The authors note that “…
improved estimate of subject specific air pollution expo-
sures would be expected to find stronger, more statistically
significant associations.”
Another study having exposure misclassification is that
of Metzger et al. (2007), conducted in the Atlanta area and
involving 518 patients with ICDs; there were found to be
no associations with tachyarrhythmias for any of the
emissions monitored (PM10, ozone, NO2, CO, and SO2
for 10 years, PM2.5 and oxygenated hydrocarbons for
4 years). Metzger et al. also discussed exposure misclassi-
fication, stating that the study “does not contribute evidence
regarding whether personal exposure may be a determinant
of ventricular tachyarrhythmia.”
Sarnat et al. (2006) examined pollutant associations with
supraventricular and ventricular arrhythmias. This was a
companion study to that of Luttmann-Gibson et al. (2006),
who examined pollution associations with reduced HRV in
Steubenville, Ohio during summer and fall 2000. Both
studies used a monitor several hundred feet higher than the
living quarters of the subjects, and about a mile distant.
Like Luttmann-Gibson et al., Sarnat et al. found associa-
tions with sulfate, but not with BC, although the companion
study also found associations with PM2.5. Exposure
misclassification for locally variable emissions such as BC
is particularly severe, as with the companion study, due to
the monitor’s height.
Anselme et al. (2007) found an immediate 200% to
500% increase in ventricular premature beats in CHF rats
compared to healthy rats exposed to diluted diesel
emissions. This finding is similar that of Dockery et al.
(2005), in which the significant pollution associations for
ventricular arrhythmias were only for those who had had a
previous arrhythmia in the previous 3 days vs. more healthy
people. The increase in arrhythmias following exposure to
diesel exhaust in Anselme et al. (2007) appears to have its
strongest parallels in the findings of Albert et al. (2007),
e.g., increases in VT/VF in subjects half an hour after being
in traffic, and of Riediker et al. (2004a, b), which found that
the “speed change” factor, marked by diesel emissions and
brake wear, was associated with significant increases of
about 40% in SVE beats. Of the four epidemiological
studies, none of which had good exposure information for
spatially variable local vehicular emissions, two neverthe-
less suggest that traffic emissions are associated with
arrhythmias, and three discussed exposure misclassification
as a possible reason for results being smaller and weaker
than had exposure information been more accurate.
The rapid initiation of arrhythmias after exposure to
diesel emissions may suggest a direct effect on the
myocardium. Anselme et al. (2007) state that such a quick
response supports the idea that agents such as ultrafines,
gasses, or soluble PM do cross the pulmonary epithelium
into the circulation. However, rapid initiation might instead
support the findings of Rhoden et al. (2005), who found
that antagonists of both the sympathetic and parasympa-
thetic nervous systems prevented oxidative stress in the
heart caused by instillation of urban PM or inhalation of
CAPs. In this second case, it might not be necessary for
pollution to enter the bloodstream; oxidative stress in the
heart due to exposure to PM (Rhoden et al.) or diesel
emissions (Anselme et al.) might cause arrhythmias via
direct modulation of the vagal nerve.
Inflammation
Initiation of an inflammatory response is another potential
mechanism underlying PM-induced cardiovascular effects.
Ridker et al. (2008) demonstrated that reducing systemic
inflammation, initially marked by levels of high-sensitivity
C-reactive protein (CRP), resulted in significant reduction
of cardiovascular events (MI; revascularization or unstable
angina; stroke; combined end point of MI, stroke, and death
from any cardiovascular cause; and death from any cause)
among those with low LDL cholesterol levels (<130 mg/dL)
but initially high CRP (>2.0 mg/L). CRP itself is not the
cause of progression of disease, however, but rather an
indicator of inflammation (Schunkert and Samani 2008).
Thus, elevated chronic systemic inflammation appears to be
a cause of increased cardiovascular mortality and morbidity,
even among apparently healthy people without hyperlipid-
emia. Systemic inflammation as marked by interleukin-6
(IL-6) is also associated with higher risks of mortality
among older female CVD patients (Volpato et al. 2001) and
with higher risks of a future MI among apparently healthy
men (Ridker at al. 2000).
Bonvallot et al. (2001) exposed human bronchial
epithelial cells to DEP and to DEP organic extracts, both
of which induced activation of pro-inflammatory NF-κB,
but the stripped carbonaceous core induced less intense
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tory cytokines such as TNF-α, IL-6, and IL-8. Bonvallot et
al. showed that DEP induced expression of a cytochrome P-
450 specifically involved in PAH metabolism. This finding
suggests the importance of PAH organic compounds in
diesel emissions in causing inflammatory responses.
McDonald et al. (2004) found that diesel emissions from
a relatively new diesel engine operating in steady state
caused significant increases in several biological endpoints
in mice, including inflammatory cytokines IL-6, TNF-α,
and INF-γ (as well as oxidative stress, as marked by HO-
1), with exposures of 200μg/m
3 (6 h/day, 7 days). Use of a
catalyzing trap eliminated virtually all the black carbon and a
large percentage of many carbonaceous emissions, and also
abolished the significant increases in cytokines and HO-1.
Tornquist et al. (2007) exposed 15 healthy men to diesel
exhaust or filtered air for 1 h. In those exposed to diesel
emissions, there were significant increases in TNF-α and
IL-6, paralleling in vitro and in vivo findings just reviewed.
Seaton et al. (1999) estimated exposure to PM10 in 108
elderly subjects in Belfast and Edinburgh, modeling
estimated personal exposures based upon activity diaries
and multiple monitoring sites. Increased CRP was signifi-
cantly associated with city center measurements of PM10,
but IL-6 was not. Another European multi-city study
(Ruckerl et al. 2007) found in pooled results a significant
increase in IL-6 per interquartile range increase (IQR) of
particle number count 12–17 h before blood withdrawal,
and per same day IQR increase in NO2 (primarily a marker
for vehicular emissions in European cities); no such
association was found with CRP.
Riediker et al. (2004a), Riediker (2007), and Delfino et
al. (2008) are examples of studies with excellent exposure
assessments. Both of the Riediker et al. studies examined
effects of 9 h of exposure to in-vehicle pollution on various
cardiovascular parameters in healthy young male patrol
officers. In Riediker et al. (2004a), elevated CRP was
significantly associated with in-vehicle PM2.5, but not with
roadside PM2.5. In Riediker (2007), IL-6 levels were
significantly increased by about 20% for a one-standard-
deviation increase in in-vehicle PM2.5. Although IL-6 was
not measured in the 2004 study, and CRP was not measured
in the 2007 study, we can reasonably conclude that both
CRP and IL-6 are elevated when healthy young men are
exposed to several hours of vehicular emissions at levels
found inside on-road vehicles.
Delfino et al. (2008) examined biomarkers of inflamma-
tion, anti-oxidant activity, and platelet activation in a panel
study of 29 non-smoking elderly with CHD in retirement
homes in Los Angeles. Using monitors just outside and
inside the residences, the authors modeled concentrations of
outdoor emissions inside the homes, where subjects spent
most of their time. Delfino et al. (2008) found that several
biomarkers of inflammation (CRP, IL-6, and soluble
receptor-II for TNF-α) increased significantly with increas-
ing exposure to various vehicular emissions (current day
and multi-day averages). Reduced anti-oxidant activity was
found for all but three subjects with several different traffic
emissions. Among PM size fractions, only the smallest
particles (“quasi-ultrafines,” PM0.25)w e r es i g n i f i c a n t l y
associated with these biomarkers, paralleling findings
regarding particles in Los Angeles taken close to freeways
with regard to oxidative stress, as reviewed above. Particle
number, BC, EC, CO, and primary OC were also associated
with one or more of the biomarkers. Interestingly, second-
ary organic carbon showed no associations.
Thus, three studies of humans exposed to ambient air
with accurate exposure monitoring found elevated levels of
inflammatory indicators CRP and IL-6 associated with
increased in-vehicle PM2.5, or with several vehicular
emissions. Of the other two studies (Seaton et al. 1999
and Ruckerl et al. 2007), one found elevated CRP in
subjects in relation to modeled central city PM10, while the
other found IL-6 was elevated relative to centrally
monitored particle number and NO2 concentrations.
Tornquist et al. (2007) found in healthy human volunteers
significant increases in IL-6, TNF-a, and soluble P-selectin
24 h after inhalation (1 h) of 300μg/m
3 diesel exhaust,
suggesting the role of diesel emissions in the epidemiolog-
ical findings noted above. Findings of these studies are in
concert with the in vitro (Bonvallot et al. 2001) and in vivo
(McDonald et al. 2004) studies reviewed above as well.
Bonvallot et al. establishes a possible biological mechanism
of inflammation involving PAHs.
Zeka et al. (2006) studied 710 members of the VA
Normative Aging Study cohort living in the greater Boston
area, with air pollution measured at a central monitor.
Despite the potential exposure misclassification, the authors
found an association for elevated CRP with an increase in
one standard deviation in BC (for those with a BMI over
30, e.g., obese). Risks of elevated CRP were approximately
four times higher for obese than for non-obese. Significant
associations were not found for CRP with other types of PM.
Those lacking a measure of genetic protection against
oxidativestress,e.g.,GSTM1-null subjects, were significantly
more likely to have increased levels of CRP associated with
increased BC concentrations. The authors discuss exposure
misclassification, noting that a limitation of the study was the
inability to measure personal exposure to different types of
PM, and that they “would expect an underestimation of the
effects of air pollution observed in the present study.”
Atherosclerosis
Atherosclerosis refers to a thickening of the luminal wall of
arteries that, depending upon the specific type of condition,
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Atherosclerosis may be considered an inflammatory disease
which progresses in concert with oxidation of LDL lipids
(Steinberg 2002). Thus, initiation or exacerbation of
inflammation, associated with pollutant exposure, may be
a mechanism for some of the health outcomes noted herein.
Studies reviewed above show links between vehicular
emissions and acute HRV reductions/oxidative stress
reactions. A study of 1,133 non-smokers in a Swiss cohort
(Probst-Hensch et al. 2008) found that those with
glutathione-S-transferase polymorphism deletions (which
reduce anti-oxidant defenses) have altered autonomic
control, as marked by reduced HRV. The authors conclude
that their results are consistent with an important patholog-
ical role for systemic, chronic oxidative stress among the
general population. Although unexplored in this study,
these findings may suggest as well that vehicular emissions
which cause acute oxidative stress and thus change in HRV
may be causally related to increases in arterial plaque
formation via oxidation of LDL cholesterol. In this regard,
Romieu et al. (2008) examined residents of a Mexico City
nursing home for 6.5 months. Mexico City’s elevated
pollution levels contain high levels of vehicular emissions,
likely resulting in increased oxidative stress. Subjects were
treated with anti-oxidants (fish oil and soy oil supplements).
Both supplements increased antioxidant activity, as mea-
sured by biomarkers of response to oxidative stimuli
[glutathione (GSH) and Cu/Zn superoxide dismutase
(SOD) activity]. Those treated with fish oil supplements,
but not soy oil, also had 72% less lipoperoxidation. These
results suggest that chronic oxidative stress caused by urban
pollution is linked to increased lipoperoxidation, likely
enhancing development of atherosclerotic plaques.
In the panel study of elderly non-smoking subjects
reviewed above, Delfino et al. (2008)a l s oe x a m i n e d
associations of platelet activation, marked by soluble P-
selectin, with various emissions. P-selectin is an adhesion
molecule which plays an important role in atherosclerosis
via leukocyte recruitment (Woollard and Chin-Dusting
2007). Delfino et al. (2008) found increased levels of
soluble P-selectin significantly associated with increased
levels of EC of outdoor origin and primary OC, suggesting
that these emissions can produce platelet activation and,
thus, advance atherosclerosis.
Araujo et al. (2008) showed that inhalation of concen-
trated ultrafine PM from close to a Los Angeles freeway,
enriched in PAHs, caused significantly larger early athero-
sclerotic lesions in genetically susceptible (apolipoprotein E-
deficient) mice inhaling concentrated PM2.5 or filtered air.
Exposure to ultrafine PM also resulted in inhibition of anti-
inflammatory capacity of plasma HDL and greater systemic
oxidative stress, in part as evidenced by upregulation of
Nrf2-regulated anti-oxidant genes. The atherosclerotic
lesions were likely caused by the combination of oxidative
stress and inflammation, as both appear to be necessary for
development of atherosclerosis (Steinberg 2002).
Studies reviewed noted above found ambient levels of
traffic emissions PM to be associated with both oxidative
stress and inflammation. Findings of Araujo et al. (2008),
with a sensitive murine model, are in concert with both the
findings of Delfino et al. (2008) and the epidemiological
results of Kuenzli et al. (2005), i.e., that people exposed to
higher annual levels of ambient air in Los Angeles had
higher prevalence of atherosclerotic plaque or of important
precursors of such plaque. The results of Araujo et al.
(2008) are also consistent with the findings of Romieu et al.
(2008), who found that lipoperoxidation in residents of a
highly polluted city was reduced by use of a common anti-
oxidant. Findings of these studies are also consistent with
findings of studies in the sections on oxidative stress and
inflammation, with regard to exposure to diesel emissions,
urban pollution, and specific emissions such as BC.
Gong et al. (2007) examined exposure to ambient
ultrafine particles that were highly enriched in redox
cycling organic chemicals in terms of promotion of
atherosclerosis in mice. The investigators found that an
interaction between diesel exhaust particles and oxidized
LDL lipids synergistically affected gene expression
corresponding to pathways relevant to vascular inflamma-
tory processes such as atherosclerosis. This study suggests
how the lipid peroxidation found in the Huang et al. (2003)
and Pereira et al. (2007) studies could lead to atheroscle-
rosis such as found by Kuenzli et al. (2005) and lip-
operoxidation as noted by Romieu et al. (2008). Similarly,
Sharman et al. (2002) found that people regularly occupa-
tionally exposed to vehicular emissions (auto mechanics)
had greater plasma susceptibility to oxidation, and, thus, a
greater risk of developing atherosclerosis than did matched
controls.
Kuenzli et al. (2005) and Jerrett et al. (2005) utilized a
modeled PM2.5 “surface” created for Los Angeles by
interpolating data from 23 fixed-site monitors, creating
within-city gradients for exposure to PM2.5. Motor vehicles
are the major source of emissions in Los Angeles, since
other potentially major stationary sources of pollution (e.g.,
coal-fired power plants, steel mills, and coke industries) are
absent. Thus, PM2.5 in the Los Angeles basin as a whole is
related primarily to vehicular emissions, although near ports
shipping emissions may also be important.
Using the ACS data base for Los Angeles, Jerrett et al.
(2005) found the relative risks for all-cause and cardiovas-
cular mortality three to four times larger than in the original
ACS study, which examined inter-city differences in PM2.5,
vs. intracity differences. Kuenzli et al. (2005) found higher
levels of PM2.5 within the Los Angeles airshed to be
associated with higher levels of atherosclerotic plaques in
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60 years old or older.). These results, suggesting that
mainly vehicular-derived PM2.5 in Los Angeles may be
causally related to the development of atherosclerosis,
parallel those of Hoffmann et al. (2007), noted above,
who found that people living close to major roads had
significantly higher levels of coronary atherosclerosis as
measured by coronary artery calcification.
Vascular function and blood pressure
Another potential mechanism by which vehicular-derived
PM could cause cardiovascular injury involves changes in
vascular tone. Urch et al. (2004, 2005) exposed healthy
human volunteers to ozone plus CAPs (concentrated
ambient particles) obtained in close proximity to a major
Toronto freeway. The resultant increase in vasoconstriction
of the brachial artery (2004 study) was associated with EC
and OC, but not with any of the other 23 components of
PM2.5 examined, suggesting traffic emissions as a likely
causal source. Diastolic blood pressure (2005 study),
possibly related to the vasoconstriction findings of the first
study, increased with increased levels of organic carbon and
was attributed to traffic emissions.
Miller et al. (2009) exposed rat aortic rings in vitro to
diesel exhaust particles (DEP) to explore mechanisms of
effects on vascular function. The authors found that
oxidative stress caused by DEP reduced the bioavailability
of endothelium-derived nitric oxide “without prior interac-
tion with the lung or vascular tissue.”
Bartoli et al. (2009) examined the effects of CAPs
collected adjacent to a major urban road on blood pressure
of dogs. Increases in systolic blood pressure (SBP), diastolic
BP (DBP), mean BP, heart rate, and rate times pressure were
all associated with an IQR increase in PM2.5, BC, and
particle count, with the size of the effect increasing in that
order (BC marginally significant for systolic pressure). As
with the studies of Urch et al. the CAPs were taken from
next to a major road, exposure was accurately known, and
the BC, carbonaceous and/or ultrafine PM (emitted from
traffic) were highly associated with the increases in BP.
Subjects in the multi-city study of Auchincloss et al.
(2008) were aged 45–84 and clinically free of CVD. The
authors found several associations between PM2.5 and pulse
pressure (PP), with only one model (which included traffic
emissions) finding associations with SBP. Further analysis
showed that when PM2.5 exposure for subjects was
stratified by either of three traffic variables (NO2 levels
above median; residence within 300 m of highway; or high
density of roads nearby residence), a 10-μg/m
3 increase in
PM2.5 was associated with increased PP (all three cases)
and SPB (two or three cases) when the traffic variable was
“positive,” but not when the traffic variable was “negative.”
Thus, PM2.5 exposure was not associated with either
endpoint unless exposure level to traffic emissions was
stratified as “high.” Using different methods of assessing
exposure to vehicular emissions in a multi-city study, these
investigators found similar SBP results to the studies above
using CAPs taken from nearby major roads.
Findings have been inconsistent with regard to elevated
blood pressure associations among studies lacking reason-
ably accurate information for exposure to locally variable
emissions, such as those from vehicles. Ibald-Mulli et al.
(2004) examined 131 subjects with coronary heart disease
in three European cities, used centrally monitored PM2.5,
accumulation mode, and ultrafine particle mass concen-
trations. Results were controlled for temperature, baromet-
ric pressure, and relative humidity. Very small negative, but
significant, associations were found for both SBP and DBP
with particles of different sizes. However, the authors
cautioned against inferring clinical relevance from these
findings. Zanobetti et al. (2004), in a study of residents of
greater Boston, found positive and significant PM2.5
associations (mean level for 5 days before physician visits)
with resting SBP, DBP, and mean arterial BP (MAP). In
addition, for those with resting heart rate >70 bpm, mean
PM2.5 level for the 2 days preceding the visit were
associated with increases in DBP and MAP during exercise.
Temperature, dew-point temperature, and barometric pres-
sure, as well as standard socioeconomic variables, were
controlled for. Pollutants were measured at central sites.
Associations were found with SO2,O 3, BC, but not with
NO2 or CO in single-pollutant models, but only PM2.5
remained associated with elevated DBP in multi-pollutant
models.
Thus, it appears that when exposure to vehicular
emissions are reasonably well characterized—as when
ambient air is from near a major road, or when results are
stratified by whether someone lives near major roads or has
a high density of roads near their residence—increased
blood pressure effects are consistently found associated
with vehicular emissions. However, in the absence of
reasonably well-characterized exposure information for
vehicular emissions, associations become inconsistent, and
vehicle-specific emissions are less likely to be associated
with change in blood pressure.
Lai et al. (2005) found that toll workers exposed to
traffic exhausts had significantly higher levels of plasma
NO, an agent affecting vascular tone, than similar workers
not so exposed, suggesting another pathway by which
vehicular emissions could adversely influence vascular
tone.
Peretz et al. (2008) exposed 27 adult volunteers (ten
healthy, 17 with metabolic syndrome) to diluted diesel
exhaust (100 or 200μg/m
3PM2.5) or filtered air. The
authors examined brachial arterial diameter change, and
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vasoconstrictor. Reduction in brachial artery diameter was
linearly related to increasing exposure concentration of the
exhaust, paralleling the findings of Urch et al. (2004),
which used CAPs from nearby a Toronto freeway, and
suggesting the importance of diesel emissions specifically
for this endpoint. Plasma levels of ET-1 were increased
only at the highest concentration of exposure.
Campen et al. (2005) found that fresh diesel emissions
can cause vasoconstriction in the blood vessels of mice ex
vivo, but that filtering diesel exhaust to remove particles
did not change the vasoconstrictive properties of the
emissions. Further analysis suggested that two specific
gaseous emissions, aldehydes and alkanes, appeared to be
responsible for these effects, suggesting a potential biolog-
ical mechanism for the findings of Urch et al. (2004, 2005).
Changes in vascular homeostasis may be due to
oxidative stress on endothelial cells or to systemic
inflammation that affects the endothelium. Peretz et al.
(2007) exposed healthy adults to diluted diesel exhaust and
used microarray techniques to assess effects in peripheral
blood leukocytes, since these cells are involved in inflam-
mation and control of vascular homeostasis, including
development of atherogenesis (Kristovich et al. 2004;
Libby et al. 2002). They noted that the diesel exhaust
exposure preferentially modulated genes involved in oxi-
dative stress, inflammation, leukocyte activation, and
vascular homeostasis, mechanisms by which adverse health
effects may be modulated.
Research recommendations
Different types of particles have different biological effects,
and some are likely to be more harmful than others; for
example, some might cause more oxidative stress. Addi-
tional effort is needed to move closer to the goal of
regulating those specific types of particles and emissions
which may have the greatest health relevance. Research
recommendations are made with this goal in mind.
First, although we suggest, based upon the data base
discussed, that creation of a black carbon PM standard
under the National Ambient Air Quality Standards may
serve to protect public health, there is still much research to
be done with regard to the different components of
vehicular emissions. Non-PM carbonaceous components
ofvehicularemissionshaveadversehealtheffects(Mauderly
and Chow 2008), but relatively little research has been done
to date on them. Even if a black carbon standard were
regulated under the NAAQS, and even if as a consequence
of such a standard, many VOC and SVOC emissions would
be controlled simultaneously, gasoline engines emit many of
the same VOCs as diesels, and many different ones as well.
Several toxicology studies of gasoline emissions, using
genetically engineered mice, have generated hypotheses
about their effects. Lund et al. (2007), in a study using
atherosclerosis-prone genetically modified ApoE
−/− mice,
showed that the gaseous fraction of gasoline emissions
were associated with increased markers of vascular oxida-
tive stress and transcriptional upregulation of factors
associated with vascular remodeling important to the
development of atherosclerosis. Campen et al. (2006),
using the same mouse model, found that fresh gasoline
emissions, but not paved road dust, altered cardiac
repolarization. Should research establish that these emis-
sions also cause serious harm to public health, technology
solutions will have to be found for these as well.
More health endpoints appear to have been examined for
diesel than for gasoline engine exhaust at this point, espe-
cially when using ambient air or human subjects or both;
thus, further research is needed. To establish a comprehen-
sive and consistent basis of comparison of gasoline with
diesel emissions, ways should be found to test gasoline
emissions in protocols using human subjects parallel to
those of Mills et al. (2005, 2007), for example.
A second research recommendation is also quite impor-
tant to determining which emissions need to be controlled to
protect public health. It may be reasonable to think that
today, there are two widespread types of air pollution of
public health concern: those from vehicles and those from
power plants, especially those using coal. Two to three
decades ago, use of residual oil use was much more
widespread than now, and the oil also contained higher
amounts of metals (V, Ni) and sulfur (Thurston and Spengler
1985). With less than 3% of electric generation from residual
oil today vs. 17% three decades ago, today’sr e s i d u a lo i l
emissions are lower and more localized. Similarly, there
were formerly more coking and non-electric arc steel plants,
and these plants did not face the emission regulations they
face today. Thus, epidemiological studies of the 1970s and
1980s would have had to be attentive to specific emissions
from these sources in more locations and on a more regional
scale than more recent studies.
Many early studies of PM did not recognize, as we now
do, either the importance of monitoring specifically for
emissions from vehicles, or the need to have reasonably
accurate exposure information for such emissions. Now that
methodologies rectifying these deficiencies are available,
we recommend they be used to examine whether cardio-
vascular effects found to be associated with vehicular
emissions, as in the studies above, are also found with
emissions representing coal emissions (secondary sulfates
and coal fly ash) as well as associated products of
atmospheric chemistry involving such emissions.
Thus, one recommendation would be to perform tests
utilizing ambient air masses, as with the work of Schwartz
18 Air Qual Atmos Health (2010) 3:3–27Table 3 Summary of effects of vehicular emissions and black carbon on CVD health endpoints
Health endpoint In vitro studies In vivo studies Human panel studies
1. Oxidative
stress
Li et al. 2002a (increases
in HO-1, diesel PM)
McDonald et al. 2004 (diesel
emissions, increased HO-1 in normal
mice; oxidative stress abolished with
use of catalyzing trap which totally
eliminated black carbon, largely
eliminated most organics, including
many PAHs)
Mills et al. 2005 (diesel emissions,
healthy human volunteers; reduction
in t-PA, impairment of vascular tone,
postulated by authors to be related to
oxidative stress; also see HRV Alter-
ation [HRV changes often caused by
oxidative stress])
Li et al. 2002b (increases in
HO-1, Los Angeles air)
Delfino et al. 2008 (decreased levels of
anti-oxidant enzyme activity, in panel
of 29 non-smoking elderly subjects
with history of coronary artery dis-
ease associated with BC, NO2, pri-
mary OC of outdoor origin, and
ultrafine PM, for current day and
multi-day averages, in study with
excellent exposure characterization,
using both indoor and outdoor mon-
itors at Los Angeles residences)
Li et al. 2003 (increases in
HO-1, most harm caused by
ultrafines in Los Angeles air,
correlated with organics and
PAHs)
2. HRV alteration NA Anselme et al. 2007 (diesel emissions,
HRV decreases in healthy and CHF
rats immediately after exposure)
Adar et al. 2007 (changes in six
different types of HRV associated
with BC exposure; when subjects on
bus with high BC levels, larger HRV
changes roughly correspond with
larger changes in BC; monitor
followed subjects wherever they went)
Schwartz et al. 2005b (changes in 4
types of HRV associated with BC
concentrations, but not with
concentrations of non-BC regional
PM2.5; subjects live on same road as
monitor is located, both in close
proximity to road, 0.5 miles apart)
Creason et al. 2001 (HRV changes
monotonically associated with
increasing PM2.5, after two days with
high PM2.5 from only rural sources
eliminated from regression)
Ebelt et al. 2005 (HRV associations
found for ambient urban PM, not
found for sulfate; personal monitors
used)
In studies using central monitors,
Wheeler et al. (2006) and Park et al.
(2005) show associations with BC in
only one fourth of tests; Luttmann-
Gibson et al. (2006) find no BC
associations.
Park et al. (2007) is same study as Park
et al. (2005), but uses wind
trajectories to determine sources, thus
has better exposure information than
Park et al. (2005); HRV associations
found for urban air masses, not for
rural air masses
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Health endpoint In vitro studies In vivo studies Human panel studies
3. ST-segment
Depression
NA Yan et al. 2008 (diesel exhaust particles
impaired left ventricular functioning
in healthy rats, with further
impairment in rats with myocardial
injury)
Mills et al. 2007 (ST-segment depres-
sion in subjects with CHD exposed
to diesel emissions twice as great as
for subjects without CHD, suggest-
ing how diesel emissions could harm
susceptible subjects)
Gold et al. 2005 (in parallel study to
Schwartz et al. 2005b HRV study,
e.g., with accurate exposure
information, ST-segment depression
associated with BC but not with
PM2.5)
Lanki et al. 2006 (in study of several
local and regional pollutants lacking
good exposure information, ST-
segment depression associated with
ABS [EU equivalent of BC] but not
with sulfate or other pollutants)
4. Cardiac
Arrhythmia
NA Anselme et al. 2007 (diesel emissions,
200% to 500% increase in ventricular
premature beats in CHF rats, but not
in normal rats)
Albert et al. 2007 (risks of ICD shock
elevated in hour after driving, RR=
2.24; risks for ventricular fibrillation
or tachycardia elevated in half hour
after driving, RR=4.46)
Riediker et al. 2004a, b (∼40% increase
in SVE beats for change of one SD in
“speed change” factor reflecting
diesel emissions and brake wear)
Ebelt et al. (2005) (SVE associations
found for ambient urban PM, non-
sulfate ambient urban PM, not found
for sulfate; personal monitors used)
Peters et al. (2000), Dockery et al.
(2005), Metzger et al. (2007), and
Sarnat et al. (2006) are extant studies
of arrhythmias using central monitor
concentrations as proxies for subject
exposure over large metropolitan
areas, causing exposure
misclassification; first study finds
larger associations with vehicular
emissions (BC and NO2) than with
PM2.5; second study finds traffic
emissions more likely cause of
arrhythmias; third study finds no
associations; associations in fourth
study are with sulfate but not with
BC; the first three studies discuss
exposure misclassification as possible
reason for underestimates of
associations
5. Vascular
Function
Miller et al. 2009 (diesel particles
reduce bioavailability of
endothelium-derived NO in aortic rat
rings in vitro via oxidative stress,
without prior interaction with lung or
vascular tissue)
Bartoli et al. 2009 (increases in mean,
systolic and diastolic blood pressure
found in dogs exposed to CAPs taken
from near major urban roadway; BC,
carbonaceous particle count
associated with increases in blood
pressure)
Urch et al. 2004 (significant increase in
vasoconstriction in healthy human
volunteers exposed to CAPs taken
from near freeway associated only
with EC and OC among 25
components of PM2.5 analyzed)
Campen et al. 2005 (fresh diesel
emissions and filtered diesel exhaust
cause vasoconstriction in mice ex
Urch et al. 2005 (significant increase in
blood pressure in healthy human
volunteers exposed to CAPs taken
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Health endpoint In vitro studies In vivo studies Human panel studies
vivo, aldehydes and alkanes
most likely involved)
from near freeway, possibly
associated with increase in
vasoconstriction in 2004 study,
related to traffic emissions)
Auchincloss et al. 2008 (in subjects
aged 45–84, systolic blood pressure
and pulse pressure associated with
increased PM2.5 only when traffic
variables (NO2 levels above median
value; residence within 300 m of
highway; or high density of roads
near residence) were “positive,” not
when traffic variables were
“negative”)
Lai et al. 2005 (toll workers exposed to
traffic exhaust had significantly
higher levels of plasma NO, which
affects vascular tone)
Peretz et al. 2007 (in healthy adult
volunteers, diesel exhaust
preferentially modulated genes
involved in oxidative stress,
inflammation, leukocyte activation
and vascular homeostasis)
Peretz et al. 2008 (in adult volunteers
exposed to diesel exhaust, reduction
in brachial artery diameter linearly
related to increasing concentration of
exhaust; plasma levels of endothelin-
1, a vasoconstrictor, significantly in-
creased only at 200μg/m
3 of diesel
exhaust, but not at 100μg/m
3)
6. Inflammation Bonvallot et al. 2001 (diesel emissions
and diesel organic extracts induced
increased levels of pro-inflammatory
NF-κB in human bronchial epithelial
cells; less intensive effects induced by
stripped carbonaceous core)
McDonald et al. 2004 (increased levels
of three inflammatory biomarkers
(TNF-α, IL-6, and INF-γ) associated
with exposure to diesel emissions,
effects abolished with use of new
catalyzing trap which eliminated BC
completely, largely eliminated most
organics, including many PAHs)
Delfino et al. 2008 (several biomarkers
for inflammation [CRP, IL-6, TNF-α
receptor] significantly increased with
increased concentrations of BC, EC,
CO, primary OC, and with increased
particle number)
Riediker et al. 2004a (CRP elevated
with increased in-vehicle PM, in
study of patrol officers after 9-h shift)
Riediker 2007 (IL-6 elevated with
increased in-vehicle PM, in study of
patrol officers after 9-h shift)
Tornquist et al. 2007 (diesel emissions
increased TNF-α, IL-6 levels in
healthy human volunteers, vs. filtered
air)
Zeka et al. 2006 (elevated BC levels,
recorded at central monitor,
associated with increased CRP levels
in the obese, and in those lacking a
measure of genetic protection against
oxidative stress, e.g., GSTM1-null
subjects. Authors discuss exposure
misclassification, note that they
would expect larger risks with better
exposure assessment)
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in regions such as north-central Pennsylvania or in central
New York State, where on most days emissions would
reflect little industrial or vehicular emissions relative to
urban locations. To be consistent with many of the studies
reviewed above, recruitment of those living in a retirement
center would be recommended. Would days with higher
total PM2.5, and/or with higher levels of sulfate, exhibit
similar changes in inflammatory indicators (CRP, IL-6),
levels of anti-oxidant enzyme activity, or adhesion mole-
cules (soluble P-selectin), as in Delfino et al. (2008)? Such
proposed studies should also examine blood pressure and
vasoconstriction, as in Auchincloss et al. (2008) and Urch
et al. (2004, 2005). ST-segment depression, oxidative
stress, and arrhythmias should also be examined in studies
paralleling those reviewed above.
Wind trajectory analysis, such as used in Park et al.
(2007) and Creason et al. (2001), and which Lippmann et
al. (2006) used to demonstrate associations with Ni from
Canadian nickel smelters on reduced HRV in mice housed
in a rural location in New York State, should also be used to
see if on days with elevated measures of health effects the
air masses might come from an unsuspected source, as in
Lippmann et al. (2006).
These studies would allow a direct comparison with the
studies examined in this assessment, and thus would enable
researchers to see if ambient coal emissions, including
reaction products, would cause the same cardiovascular
health effects as diesel and/or vehicular emissions. Recom-
mendation of research of this type, however, is not to
recommend that more innovative research is any less
important. For instance, the “highway gradient” studies are
an example of the kind of innovation that caused researchers
to focus on biological mechanisms of vehicular emissions.
More generally, the use of new personal monitoring
tools, such as vests being developed by EPAwhich are easy
to wear and monitor many different emissions, may
broaden the endpoints which can be examined with regard
to pollution associations. Arrhythmias would be one
primary endpoint, since up to now, central monitors have
been used to provide pollution data in studies of arrhyth-
mias. Since this health endpoint has not yet apparently been
examined in studies using accurate exposure information
for vehicular emissions, arrhythmias would be an excellent
candidate for use in studies with better monitoring, perhaps
using the protocols of Schwartz et al. (2005b) and Gold et
al. (2005). Furthermore, although V and Ni now tend to be
relatively local emissions (e.g., near major ports as shipping
fuel and in a few Northeastern locales), it is still important
to separate effects of metals from carbonaceous materials.
Conclusions
Epidemiologic studies with good exposure information for
locally variable levels of particulate emissions from motor
vehicles consistently find associations between such expo-
sure and cardiopulmonary disease mortality, circulatory
disease mortality, ischemic heart disease mortality, and all-
cause mortality, and with many CV morbidity endpoints,
such as cardiovascular hospital admissions, markers of
atherosclerosis, survival after heart failure, incidence of
Table 3 (continued)
Health endpoint In vitro studies In vivo studies Human panel studies
7. Atherosclerosis
and
lipoperoxidation
See oxidative stress and inflammation
sections for in vitro work relevant to
atherosclerosis, caused in large part
by systemic interaction of oxidative
stress and inflammation
Araujo et al. 2008 (increased early
atherosclerotic lesions in ApoE
-/-
mice breathing CAPs ambient in
PAHs from near LA freeway,
exposure to ultrafine PM inhibited
anti- inflammatory capacity of plasma
HDL)
Sharman et al. 2002 (auto mechanics,
regularly exposed to higher levels of
vehicular emissions than controls, had
significantly higher susceptibility of
plasma to oxidation)
Gong et al. 2007 (interaction between
oxidized LDL lipids and organic
diesel emission extracts affects gene
expression relevant to vascular
inflammation and atherosclerotic
pathways in human microvascular
endothelial cells; work then replicated
in vivo, with similar findings – see in
vivo, next column)
Gong et al. 2007 (interaction between
oxidized LDL lipids and concentrated
ultrafine diesel exhaust particles in
Los Angeles air affects gene
expression corresponding to
atherosclerotic pathways in mice,
viewed by authors as confirming in
vitro findings in column to left)
Delfino et al. 2008 (levels of soluble P-
selectin, important for platelet activa-
tion in atherosclerosis, significantly
associated with increased levels of
EC of outdoor origin, primary OC, in
study of seniors in Los Angeles)
Huang et al. 2003 (PM1.0 more likely
to cause lipoperoxidation in human
lung cells than larger fractions, OC
and EC but not various ions
associated with this effect)
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acute myocardial infarction. For each of the cardiovascular
health endpoints reviewed herein—oxidative stress, HRV
changes, ST-segment depression, inflammation, arrhythmia,
vascular function and blood pressure, and atherosclerosis—
there are mechanistic studies supporting a pathophysiolog-
ical basis for how diesel and/or vehicular emissions could
cause such outcomes. The mechanistic studies for each
endpoint are briefly summarized in Table 3.T h e s e
cardiovascular health endpoints, in turn, provide multiple
biological mechanisms with explanatory value for the
mortality and morbidity findings in the epidemiology studies.
A number of the studies reviewed in this paper examined
human subjects breathing ambient air. Such studies are
likely to provide information most relevant to regulations
designed to protect public health. Studies using genetically
modified animals and highly concentrated components of
ambient air, or using artificial atmospheres, are useful in
generating hypotheses, but if these hypotheses are not
verified in people exposed to ambient atmospheres, they
may not provide an adequate basis for regulation. The
database of ambient air studies does provide substantial
evidence that the cardiovascular health effects associations
with vehicular emissions likely reflect causality, rather than
just statistical correlation.
Studies have shown that emissions from diesel engines
may be especially potent in producing adverse health
outcomes (U.S. Environmental Protection Agency 2002).
As of January 2007, EPA regulations require a new
catalyzing trap on all new on-road diesels. These devices
reduce BC levels virtually completely, while also reducing
emissions of many carbonaceous species by large percen-
tages (McDonald et al. 2004). BC is likely an important
causal agent of effects with which it has been associated in
many studies, both intrinsically and because many carbo-
naceous species co-emitted from diesels and other vehicles
can be adsorbed onto the surface of BC. In addition, BC is
also likely a marker for harmful carbonaceous gasses which
may be co-emitted with but not adsorbed onto the particles.
The EPA regulations do not extend to retrofits, however,
and older diesels are the worst emitters. Several states are
taking action to reduce such diesel emissions. In California,
there are now proposals to restrict diesels from prior to a
particular vintage year from operating in the ports of Los
Angeles and Long Beach, unless retrofitted with the new
catalyzing trap. Several localities are now requiring retrofit
programs on certain classes of vehicles, e.g., school buses,
or are advancing the replacement date for older diesel
buses. A “speciated” BC standard would be more compre-
hensive than a patchwork of state requirements, and would
likely cause many states to require retrofits of catalyzing
traps on older diesels. This would reduce not just BC, but
also the associated carbonaceous emissions which adsorb
onto BC and also may cause health effects per se. Further, a
speciated BC standard would require states to deal with BC
in areas not in violation of standards for PM2.5, but where
diesel health effects would be of consequence to public
health. If it made sense to require new technology on new
on-road and off-road diesels—and we agree that it does—
then it makes even more sense to control emissions from
the older, dirtier diesels which will be in operation for
perhaps another 30 years.
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